Cargando…

Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief

The hypothesis that sustained G protein-coupled receptor (GPCR) signaling from endosomes mediates pain is based on studies with endocytosis inhibitors and lipid-conjugated or nanoparticle-encapsulated antagonists targeted to endosomes. GPCR antagonists that reverse sustained endosomal signaling and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hegron, Alan, Peach, Chloe J., Tonello, Raquel, Seemann, Philipp, Teng, Shavonne, Latorre, Rocco, Huebner, Harald, Weikert, Dorothee, Rientjes, Jeanette, Veldhuis, Nicholas A., Poole, Daniel P., Jensen, Dane D., Thomsen, Alex R. B., Schmidt, Brian L., Imlach, Wendy L., Gmeiner, Peter, Bunnett, Nigel W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235985/ https://www.ncbi.nlm.nih.gov/pubmed/37216510 http://dx.doi.org/10.1073/pnas.2220979120

Ejemplares similares

Mice expressing fluorescent PAR(2) reveal that endocytosis mediates colonic inflammation and pain
por: Latorre, Rocco, et al.
Publicado: (2022)

A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes
por: Mai, Quynh N., et al.
Publicado: (2021)

Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice
por: De Logu, Francesco, et al.
Publicado: (2022)

Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
por: Budzinski, Julian, et al.
Publicado: (2021)

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action
por: Prague, Julia K., et al.
Publicado: (2018)

Investigation of Neurokinin‐1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs
por: Grobman, M., et al.
Publicado: (2016)

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial
por: Prague, Julia K, et al.
Publicado: (2017)

Interactions Between Neurokinin B and Kisspeptin in Mediating Estrogen Feedback in Healthy Women
por: Skorupskaite, Karolina, et al.
Publicado: (2016)

Structural insights into the activation of neurokinin 2 receptor by neurokinin A
por: Sun, Wenjing, et al.
Publicado: (2022)

Neurokinin B Regulates Gonadotropin Secretion, Ovarian Follicle Growth, and the Timing of Ovulation in Healthy Women
por: Skorupskaite, Karolina, et al.
Publicado: (2017)

Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission
por: Singewald, Georg M, et al.
Publicado: (2007)

Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome
por: Skorupskaite, Karolina, et al.
Publicado: (2020)

Selective G protein signaling driven by Substance P-Neurokinin Receptor dynamics
por: Harris, Julian A., et al.
Publicado: (2021)

Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
por: Ständer, Sonja, et al.
Publicado: (2010)

Neurokinin 3 Receptor Antagonists Do Not Increase FSH or Estradiol Secretion in Menopausal Women
por: Prague, Julia K, et al.
Publicado: (2019)

Investigating the KNDy Hypothesis in Humans by Coadministration of Kisspeptin, Neurokinin B, and Naltrexone in Men
por: Narayanaswamy, Shakunthala, et al.
Publicado: (2016)

Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease‐activated receptor‐2
por: Lieu, T, et al.
Publicado: (2016)

Effects of Neurokinin B Administration on Reproductive Hormone Secretion in Healthy Men and Women
por: Jayasena, Channa N., et al.
Publicado: (2014)

Neurokinin-2 receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor
por: Nguyen, Lan Phuong, et al.
Publicado: (2023)

Neurokinin-1 Receptor Inhibition and Cough
por: Turner, Richard D., et al.
Publicado: (2021)

Neurokinin 1 Receptor Antagonists for Pruritus
por: Alam, Majid, et al.
Publicado: (2021)

Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and β-arrestins
por: Padilla, Benjamin E., et al.
Publicado: (2007)

Neurokinin-1 Receptor Activation in Globus Pallidus
por: Chen, Lei, et al.
Publicado: (2009)

Mapping of neurokinin-like immunoreactivity in the human brainstem
por: Coveñas, Rafael, et al.
Publicado: (2003)

The pharmacology of neurokinin receptors in addiction: prospects for therapy
por: Sandweiss, Alexander J, et al.
Publicado: (2015)

Neurokinin-1 Receptor Antagonists against Hepatoblastoma
por: Muñoz, Miguel, et al.
Publicado: (2019)

Neurokinin receptors and their implications in various autoimmune diseases
por: Mishra, Amrita, et al.
Publicado: (2021)

Differential allosteric modulation within dopamine D(2)R - neurotensin NTS1R and D(2)R - serotonin 5-HT(2A)R receptor complexes gives bias to intracellular calcium signalling
por: Plach, Michael, et al.
Publicado: (2019)

Functionally selective activation of the dopamine receptor D(2) is mirrored by the protein expression profiles
por: Wenk, Deborah, et al.
Publicado: (2021)

Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells
por: Koh, Yung-Hua, et al.
Publicado: (2012)

Fluorescent ligands for dopamine D(2)/D(3) receptors
por: Allikalt, Anni, et al.
Publicado: (2020)

The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer
por: Rosso, Marisa, et al.
Publicado: (2012)

Neurokinin B and pre-eclampsia: a decade of discovery
por: Page, Nigel M
Publicado: (2010)

Neurokinin B Administration Induces Hot Flushes in Women
por: Jayasena, Channa N., et al.
Publicado: (2015)

An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis
por: Pal, Saumen, et al.
Publicado: (2006)

Erratum to “The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer”
por: Rosso, Marisa
Publicado: (2012)

Involvement of midbrain tectum neurokinin-mediated mechanisms in fear and anxiety
por: Brenes, J.C., et al.
Publicado: (2012)

Treating hot flushes with a neurokinin 3 receptor antagonist
por: Prague, Julia K., et al.
Publicado: (2017)

Effect of neurokinin-1-receptor blockage on fracture healing in rats
por: Hofman, Martijn, et al.
Publicado: (2019)

Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors
por: Wtorek, Karol, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v8pp8kfe02ha9prcd9ckk0j5h5